ATG9B and colorectal carcinoma: Furthermore, the combination prevented the binding of STUB1, indicating that the ATG9B and MYH9 interaction may cause a structural change for each other, and resulted in the reduction of ubiquitination and degradation, thus maintaining high protein expression level of ATG9B and MYH9 in CRC cells.